DIABETES TESTING AND MANAGEMENT CONFERENCE

5 February 2018

5.25 CME Points

Za’abeel Hall 3, Conference Room 3

Overview

Clinical‐laboratory correlations are the most important part of everyday practice in the era of modern clinical medicine. Laboratory or other diagnostic tests do not define specific clinical entity or disease; however, they are very useful to make decision related to complicated diagnostic procedures and therapies, especially for diabetes.

To establish a successful functioning of the patient‐physician laboratory triangle in interpreting lab tests, MEDLAB brings you the Diabetes Testing Conference which will focus on clinical‐laboratory correlations and communication diagnostic process.

Key topics:

Assessing beta cell function
Challenge in HbA1c measurements
Genomics in diabetes

Benefits of attending:

  • Identify causes of diabetes beyond type 1 and 2 to improve diagnosis and patient outcome
  • Discuss the genetics behind diabetes to review use of predictive genetic tests
  • Understand evidence-based recommendations for the use of laboratory testing for patients with diabetes
  • Understand basic pathology of Diabetes Mellitus for rapid interpretation and analysis of lab report
  • Strengthen communication and professional relationships between clinicians and laboratory workers to improve reliability of diagnostic tests

Chair: Dr Fayha S Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

Activity Director: Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics | Beckman Coulter | Siemens Healthineers

Provided by:

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics
Beckman Coulter
Siemens Healthineers

09.50

Opening remarks by the chair:

Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

Session 1

Moderator: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAEUAE

10:00

Epidemiology screening tools for the diagnosis of Diabetes Mellitus

Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

10:30

Bariatric surgery for diabetes

Dr Salah Abusnana, Medical Director, Rashid Centre for Diabetes and Research,
Ajman, UAE

11:00 Coffee Break


11.30

Glycated Albumin; More than a Biomarker of Glycemic Control

Dr Shereen Atef, Consultant Clinical Pathologist, National Reference Laboratory, Abu  Dhabi, UAE

12:00 Lunch Break


Session 2 :

Moderator: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE 

13.30

Diabetes and ketone bodies

Moderator: Dr Hubert Penninckx, Specialist Endocrinologist and Diabetologist, American Hospital, Dubai, UAE

14.00

Diabetes diagnosis in paediatrics

Dr Hanaa Zidan, Specialist, Paediatric Endocrinology and Diabetologist, American Hospital, Dubai, UAE 

14.30

Screening laboratory and diagnosis of Gestational Diabetes Mellitus

Prof Riad Al Bayoumi, Professor of Basic Medical Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health Care City, Dubai, UAE

15:00 Coffee Break

Session 3

Moderator: Dr Hubert Penninckx, Specialist Endocrinologist and Diabetologist, American Hospital, Dubai, UAE

15.30

The pros and cons of diagnosing diabetes with HbA1c

Dr Leslie Lam, Head & Senior Consultant, Laboratory Medicine, Ng Teng Fong General Hospital and Jurong Community Hospital, Singapore;

16:15

Management of chronic diabetes mellitus – clinical case (Type 1 DM and Hypoglycemia)

Dr Alaa Eldin Mohammed Khidir, Consultant Endocrinologist, Dubai Hospital, Dubai, UAE


17:00 End of Lab Testing and Management of Diabetes Conference

Supported by:

ACTIVITY DIRECTORS:

Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award
(SITA), Dubai, UAE

Dr Fadi W. Abdul–Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Lab Med Institute, Cleveland Clinic, Cleveland, Ohio, USA


 

PLANNING COMMITTEE:

Conference Chair: Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

Dr Hubert Penninckx, Specialist Endocrinologist & Diabetologist, American Hospital, Dubai, UAE

SPEAKER FACULTY:

Dr Alaa Eldin Mohammed Khidir, Consultant Endocrinologist, Dubai Hospital, Dubai, UAE

Dr Hanaa Zidan, Specialist, Paediatric Endocrinology and Diabetologist, American Hospital, Dubai, UAE

Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Leslie Lam, Head & Senior Consultant, Laboratory Medicine, Ng Teng Fong General Hospital and Jurong Community Hospital, Singapore

Prof Riad Al Bayoumi, Professor of Basic Medical Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health Care City, Dubai, UAE

Dr Salah Abusnana, Medical Director, Rashid Centre for Diabetes and Research, Ajman, UAE

Dr Shereen Atef, Consultant Clinical Pathologist, National Reference Laboratory, Abu Dhabi, UAE



Supported by: